- Home
- FLYX vs CCEL Comparison
FLYX vs CCEL Comparison
Compare FLYX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- CCEL
- Stock Information
- Founded
- FLYX 2015
- CCEL 1989
- Country
- FLYX United States
- CCEL United States
- Employees
- FLYX N/A
- CCEL N/A
- Industry
- FLYX Blank Checks
- CCEL Managed Health Care
- Sector
- FLYX Finance
- CCEL Health Care
- Exchange
- FLYX Nasdaq
- CCEL Nasdaq
- Market Cap
- FLYX 39.4M
- CCEL 39.9M
- IPO Year
- FLYX N/A
- CCEL 1997
- Fundamental
- Price
- FLYX $2.39
- CCEL $4.75
- Analyst Decision
- FLYX
- CCEL Strong Buy
- Analyst Count
- FLYX 0
- CCEL 1
- Target Price
- FLYX N/A
- CCEL $8.50
- AVG Volume (30 Days)
- FLYX 13.5K
- CCEL 7.9K
- Earning Date
- FLYX 08-13-2025
- CCEL 07-15-2025
- Dividend Yield
- FLYX N/A
- CCEL 12.47%
- EPS Growth
- FLYX N/A
- CCEL N/A
- EPS
- FLYX N/A
- CCEL N/A
- Revenue
- FLYX $335,427,000.00
- CCEL $31,988,783.00
- Revenue This Year
- FLYX $28.47
- CCEL $1.75
- Revenue Next Year
- FLYX $22.44
- CCEL N/A
- P/E Ratio
- FLYX N/A
- CCEL N/A
- Revenue Growth
- FLYX 5.38
- CCEL 1.10
- 52 Week Low
- FLYX $1.79
- CCEL $4.68
- 52 Week High
- FLYX $4.90
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- FLYX 47.90
- CCEL 43.86
- Support Level
- FLYX $2.01
- CCEL $4.80
- Resistance Level
- FLYX $2.59
- CCEL $5.24
- Average True Range (ATR)
- FLYX 0.24
- CCEL 0.28
- MACD
- FLYX 0.00
- CCEL -0.00
- Stochastic Oscillator
- FLYX 55.16
- CCEL 11.29
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.